The next wave of agbio products issuing will involve changes to plant traits such as nutrition and crop yield. These kinds of changes, however, could require specific, permanent changes to target genes in plants, something that researchers have not been able to do reliably and efficiently.

One solution to the problem could be Kimeragen Inc.'s chimeraplasty gene alteration technology. Although chimeraplasty has its skeptics, it is reported to show promise as a technique for altering plant genes directly rather than introducing foreign genes to